Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis,
Location: Dallas TX, Waco TX, Georgetown TX, Austin TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT06920043

Phase2, Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Fort Worth TX, Little Rock AR, Columbia MO, St Louis MO,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00358943

Recruiting

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

for
Overactive Bladder (OAB), Urinary Urgency,
Location: Dallas TX, Birmingham AL, Chicago IL, Madison WI,
Sponsor: Medstar Health Research Institute

Sex: Female

Age: 22+

Code: NCT06797245

Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Dallas TX, Atlanta GA, Indianapolis IN, Rochester MN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

DETECT-RPC Universal EM Screening

for
Elder Abuse, Elder Mistreatment
Location: Dallas TX, Houston TX, Birmingham AL, Baltimore MD,
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18+

Code: NCT05958654

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

for
PSC
Location: Dallas TX, Indianapolis IN, Rochester MN, Miami FL,
Sponsor: PSC Partners Seeking a Cure

Sex: All

Age: 18 - 70+

Code: NCT06297993

Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Dallas TX, Oklahoma City OK, Houston TX, San Antonio TX,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase2, Phase3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Dallas TX, Denison TX, Austin TX, Fredericksburg TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase2, Recruiting

Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

for
Anesthesia, Propofol Adverse Reaction,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT05358535

Phase3, Recruiting

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Cytokinetics

Sex: All

Age: 40 - 70+

Code: NCT06793371

Phase2, Recruiting

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

for
Phenylketonuria (PKU)
Location: Dallas TX, New Orleans LA, Nashville TN, Aurora CO,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 0+

Code: NCT05813678

Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Nashville TN,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

for
Coagulation Disorder
Location: Dallas TX, Tulsa OK, Arkansas City AR, Englewood CO,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT05156983

Phase3, Recruiting

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for
Advanced Hepatocellular Carcinoma
Location: Dallas TX, Houston TX, Chicago IL, Charlotte NC,
Sponsor: Iterion Therapeutics

Sex: All

Age: 18+

Code: NCT05797805

Phase1, Phase2, Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
Location: Plano TX, Round Rock TX, Oklahoma City OK, Houston TX,
Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Dallas TX, Daphne AL, Grand Island NE, Nashville TN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

for
Autoimmune Hepatitis, Primary Sclerosing Cholangitis
Location: Dallas TX, St Louis MO, Indianapolis IN, Cincinnati OH,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05750498

Recruiting

Comparison of Uncomplicated Candidemia Therapy Duration in Children

for
Invasive Candidiasis
Location: Dallas TX, Austin TX, Little Rock AR, St Louis MO,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0+

Code: NCT05763251

Recruiting

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

for
Insomnia Disorder
Location: Plano TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 2 - 17

Code: NCT06953869

Phase3, Recruiting